- £169.69bn
- £188.02bn
- $45.81bn
- 73
- 15
- 48
- 39
REG - AstraZeneca PLC - AstraZeneca and Neurimmune sign deal for NI006
AnnouncementREG - AstraZeneca PLC - Transfer of rights to Eklira, Duaklir completed
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca and Ionis close eplontersen deal
AnnouncementREG - AstraZeneca PLC - Ultomiris accepted for FDA Priority Review for gMG
AnnouncementREG - AstraZeneca PLC - Tezspire approved in the US for severe asthma
AnnouncementREG - AstraZeneca PLC - Saphnelo recommended for EU approval for SLE
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Evusheld US FDA EUA
AnnouncementREG - AstraZeneca PLC - AstraZeneca, Ionis to collaborate on eplontersen
AnnouncementREG - Schroder UK PublicPT - BenevolentAI Transaction
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Lynparza granted FDA Priority Review for OlympiA
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AZN: Year to date and Q3 2021 results
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
Announcement